About Prolacta Bioscience
Prolacta Bioscience is a Healthcare company based in Los Angeles (United States) founded in 1999. Human milk-based nutritional products for premature infants are developed. Prolacta Bioscience has raised $97.88 million across 10 funding rounds from investors including PROOF, Aisling Capital and Health Evolution Partners. Its website prolacta.com draws about 17 thousand monthly visits. Its focus areas include Life Sciences, Nutraceuticals Tech, Functional Foods and Beverages and Probiotic Drinks. Its competitors include Wellements, Healthy Times and BioNascent; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 1999 and based in Los Angeles, United States, Prolacta Bioscience operates in the biotechnology sector focused on neonatal nutrition. Standardized formulations derived from donated human breast milk are produced for premature infants in neonatal intensive care units. Surplus milk is sourced through affiliate milk banks. Key products include Prolact, Premielact Prolact HM, Prolact CR, and Prolact RTF, with clinical studies indicating improved health outcomes.
- Total Equity Funding$97.88M (USD)
in 10 rounds
- Latest Funding Round$9M (USD), Series E
May 2018
- InvestorsPROOF
& 12 more
Apps and channels of Prolacta Bioscience
its YouTube channel Prolacta Bioscience has 3.83K subscribers and 30 videos.
Videos from Prolacta Bioscience
The most watched videos on Prolacta Bioscience's YouTube channel, Prolacta Bioscience (3.83K subscribers). Click a video to play it here.
More on Prolacta Bioscience.
Funding Insights of Prolacta Bioscience
Prolacta Bioscience has successfully raised a total of $97.88M across 10 strategic funding rounds. The most recent funding activity was a Series E round of $9 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $97.88M
- Total Rounds 10
- Last Round Series E — $9M
- First Round $844,726
(Jun 2004)
- Investors Count 13
All 10 funding rounds of Prolacta Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2018 | $9M | Series E | – | – | – |
| May 2017 | $3.25M | Series E | – | PROOF | – |
| Dec 2016 | $35M | Series E | – | EW Healthcare Partners | |
| Nov 2011 | $20M | Series D | – | Health Evolution Partners | – |
| Aug 2011 | $5.78M | Series C | – | – | – |
| May 2007 | $12M | Series C | – | Alta Partners | |
| Oct 2006 | $6.69M | Series B | – | Arcturus Capital, Mercury Fund | |
| Jul 2006 | $2.15M | Series A | – | – | – |
| Jun 2005 | $4M | Series A | – | Draper Associates, Draper Richards | – |
| Jun 2004 | $844,726 | Unspecified | – | – | – |
13 investors in total: 13 institutional.
Investors in Prolacta Bioscience
Prolacta Bioscience has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include PROOF, Aisling Capital and Health Evolution Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage technology companies are funded by this venture capital firm. | proof.vc | Reston, United States | ||
PE firm investing in the US | aislingcapital.com | New York, United States | ||
| healthevolutionpartners.com | ||||
Growth-stage healthcare companies are invested in by EW Healthcare Partners. | ewhealthcare.com | New York, United States | ||
Venture capital firm focused on healthcare companies | altapartners.com | Jackson, United States | ||
US focused early-stage VC firm | arcturusvc.com | Pasadena, United States | ||
Seed & early-stage micro VC firm investing in the US | draperfrontier.com | Los Angeles, United States | ||
Early-stage investments are directed toward US, India, and Canada firms. | mercuryfund.com | Houston, United States | ||
| funkventures.com | ||||
Early-stage US investments are handled by this family office. | gideonhixon.com | Summerland, Canada |
Investor details for Prolacta Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Prolacta Bioscience
114 people are tracked at Prolacta Bioscience (45 in leadership, 69 in team).
| Name | Role | Group |
|---|---|---|
Mike Garelick | Director, Patents | Leadership |
Alva Bart | Supply Chain Director | Leadership |
Kate O'Connor Masse | Sr. Director, Reimbursement & Corporate Contracts | Leadership |
Ed Boylan | Director Health Economics | Leadership |
Rob Schuurs | Director Supply Chain Europe And Middle East | Leadership |
Pat Mason | Director, Payer Relations | Leadership |
Scott Eaker | Chief Operations Officer | Leadership |
Ellen Cushing | VP, Sales & Marketing | Leadership |
Brian Harrington | Senior Director, Supply Chain | Leadership |
Sherry Asbill | Lead Director Payer Relations | Leadership |
Armando Montoya | Director, Manufacturing | Leadership |
Mark German | Director of Professional Services | Leadership |
Yifan Li | Director Of Infrastructure & Cybersecurity | Leadership |
Scott Elster | CEO | Leadership |
Dorine Rubalcaba | Director of Marketing | Leadership |
Michelle Belanger | Director of Finance | Leadership |
John M. Shields | Vice President Legal Affairs, General Counsel & Secretary | Leadership |
David Steinberg | Chief Financial Officer | Leadership |
Adam Sun | Vice President, Research & Development | Leadership |
James Earngey | Director | Leadership |
94 more people are available in the full profile.
Complete people profiles for Prolacta Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Prolacta Bioscience
3 dated milestones of Prolacta Bioscience across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Prolacta Bioscience is founded.
- Funding First funding round of $845K.
- Funding Latest funding round, Series E, of $9.0M.
Competitors of Prolacta Bioscience
Prolacta Bioscience has 3 listed competitors in our database, 2 of them funded. They include Wellements, Healthy Times and BioNascent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wellements.com | 2000 | Phoenix, United States | $1.5M | Organic baby wellness products and supplements are manufactured for infants. | ||
| healthytimes.com | 1980 | San Diego, United States | Manufactures and distributes organic baby food products. | |||
| bionascent.co | 2016 | San Francisco, United States | $250,000 | Infant health products based on breast milk proteins are developed. |
Detailed competitors of Prolacta Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Prolacta Bioscience
The website of Prolacta Bioscience (prolacta.com) receives about 17K visits a month.
- Monthly visits17K
▲ 10% vs previous month
Websites whose visitors overlap most with Prolacta Bioscience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
mothersmilk.org | mothersmilk.org | 100% | #2,288,558 | – | |
birthingforlife.com | birthingforlife.com | 85% | – | ||
hmbana.org | hmbana.org | 77% | #2,144,334 | – | |
milkbank.org | milkbank.org | 59% | #2,988,558 | – | |
medelabreastfeedingus.com | medelabreastfeedingus.com | 53% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Prolacta Bioscience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as Prolacta Bioscience (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | 910 | ||
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | |||
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Prolacta Bioscience
Complete news archive for Prolacta Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prolacta Bioscience
Prolacta Bioscience was founded in 1999 and raised its 1st funding round 5 years after it was founded.
Prolacta Bioscience is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Prolacta Bioscience is a funded company, having raised a total of $97.88M across 10 funding rounds to date. The company's 1st funding round was a Unspecified of $844.73K, raised on Jun 2004.
Founded in 1999 and based in Los Angeles, United States, Prolacta Bioscience operates in the biotechnology sector focused on neonatal nutrition. Standardized formulations derived from donated human breast milk are produced for premature infants in neonatal intensive care units. Surplus milk is sourced through affiliate milk banks. Key products include Prolact, Premielact Prolact HM, Prolact CR, and Prolact RTF, with clinical studies indicating improved health outcomes.
Prolacta Bioscience's top competitors include Wellements, BioNascent and Healthy Times.
Prolacta Bioscience has 13 investors. Key investors include PROOF, Aisling Capital, Health Evolution Partners, EW Healthcare Partners, and Alta Partners.